Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

NCT00005612 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Ovarian Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: carboplatin
DRUG: cyclophosphamide
DRUG: etoposide
DRUG: paclitaxel
DRUG: topotecan hydrochloride
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]